The Second Affiliated Hospital Of Chongqing Medical University
Clinical trials sponsored by The Second Affiliated Hospital Of Chongqing Medical University, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New imaging technique aims to reduce lung damage during cancer radiation Results expected Dec 2026 (estimated)
- Could a new anesthetic keep your mind sharper after a procedure? Results expected Dec 2026 (estimated)
- Hepatitis b cure breakthrough? new combo aims for 50%+ cure rate Results expected Dec 2026 (estimated)
- New combo aims to cure hepatitis b in over half of patients Results expected Dec 2026 (estimated)
- New combo therapy aims to cure hepatitis b in over half of patients Results expected Dec 2026 (estimated)
-
Hepatitis b cure breakthrough? new combo aims for 50%+ cure rate
Cure Recruiting nowThis study tests a new two-drug combination (ASC22 and Peg-IFNa) to see if it can functionally cure chronic hepatitis B. About 150 adults with low virus levels will receive the treatment. The goal is to raise the cure rate above 50% without needing lifelong medication.
Phase 4 • Sponsor: The Second Affiliated Hospital of Chongqing Medical University • Aim: Cure
Last updated Sep 03, 2026 00:00 UTC
-
New combo therapy aims to cure hepatitis b in over half of patients
Disease control Recruiting nowThis phase 2 trial tests a new combination of an anti-PD-1 antibody (a type of immunotherapy) plus standard antiviral drugs in 120 adults with chronic hepatitis B. The goal is to achieve a functional cure, where the virus is no longer active and patients can stop medication. The …
Phase 2 • Sponsor: The Second Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New combo aims to cure hepatitis b in over half of patients
Disease control Recruiting nowThis phase 2 trial tests a combination of an anti-PD-1 antibody, interferon, and standard antiviral drugs in 120 adults with chronic hepatitis B. The goal is to boost the immune system to clear the virus and achieve a functional cure, where the virus stays under control without l…
Phase 2 • Sponsor: The Second Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Smaller stent, bigger hope: new TIPS technique aims to prevent brain fog
Disease control Recruiting nowThis study tests a technique called 'underdilated stent' during a liver shunt procedure (TIPS) for people with cirrhosis. The goal is to see if using a smaller balloon to place the stent can lower the risk of hepatic encephalopathy (brain confusion) after the procedure, while sti…
Sponsor: The Second Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New imaging technique aims to reduce lung damage during cancer radiation
Symptom relief Recruiting nowThis study tests whether a special imaging method (4DCT) can help doctors avoid giving too much radiation to healthy, working parts of the lung during radiotherapy for lung cancer. About 100 adults with lung cancer will receive standard radiation, but their treatment plan will be…
Sponsor: The Second Affiliated Hospital of Chongqing Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC